Active ingredientElsulfavirineCat. No. P-E026-001CAS 868046-19-9Family · Pharmaceutical analytical standards
Elsulfavirine
An antiretroviral of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, developed in Russia and approved there in June 2017 for HIV-1, taken by mouth together with other antiretrovirals. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?It is a prodrug: the body converts it into the active form, deselsulfavirine, and long-acting injectable versions of both have been studied.
Go to the active ingredient →Active ingredientElsulfavirineCat. No. P-E026-001CAS 868046-19-9
NitrosamineN1-Nitroso ElsulfavirineCat. No. P-E026-004
NitrosamineN2-Nitroso ElsulfavirineCat. No. P-E026-005
ImpurityDespropionyl ElsulfavirineCat. No. P-E026-006CAS 867365-76-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.